UPC APP 59539/2024

—·EP3346403: DATA PROCESSING, ANALYSIS METHOD OF GENE EXPRESSION DATA TO IDENTIFY ENDOGENOUS REFERENCE GENES

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
GXD-Bio Corporation
Reps: Rauh (Vossius & Brinkhof UPC Litigators)
Respondents
Myriad International GmbH
Myriad GmbH
Myriad Service GmbH
Myriad Genetics GmbH
Myriad Genetics S.A.S.
Myriad Genetics B.V.
Myriad Genetics S.r.l.
Myriad Genetics, Inc.
Eurobio Scientific
Reps: Hölder (Hoffmann Eitle)
Division: Munich LD
Judges: Ulrike Voß · Presiding judge and judge-rapporteur
Technology: Biotechnology
Language: —
First decided: Nov 26, 2024

Decisions

2024-11-26
CostsGeneric application
The Munich Local Division considered the defendants' application for security for costs from the claimant GXD-Bio Corporation (a Korean IP monetization/NPE company), finding the claimant had insufficient financial resources based on credit rating and corporate structure evidence. The court addressed the appropriate level of security under Rule 158 RoP.
Legal issues:Security for costs from NPE/IP monetization claimant under Rule 158 RoPAssessment of financial resources of foreign claimant

Documents